Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Abraxis BioScience, a fully integrated personalized healthcare company, has appointed Leon Moulder Jr as its new vice chairman, president and CEO.
Subscribe to our email newsletter
Patrick Soon-Shiong, who held the positions of chairman and CEO of Abraxis BioScience since founding the company, will assume the role of executive chairman and CEO of Abraxis Health.
Mr Moulder most recently served as vice chairman of Eisai Corporation of North America following Eisai’s acquisition of MGI Pharma, where he served as president and CEO since 2003. He joined MGI Pharma in 1999 as executive vice president and was promoted to president and COO in 2002.
The company also announced the senior management team for Abraxis Health, which will focus on biomarkers and personalized medicine. Dr Soon-Shiong will assume the role of CEO, Edward Geehr will be the president and COO and Bruce Wendel will be vice chairman and executive vice president of global business development. Dr Geehr joined Abraxis BioScience in October 2008 as executive vice president of operations.
Dr Soon-Shiong said: “Lonnie is a 25-year veteran of the healthcare industry and has a stellar track record of growing companies. His experience with pharmaceutical and biotechnology companies, particularly in the oncology area, combined with commercialization and drug development acumen makes him an ideal executive to lead the company to exceptional levels of growth.”